Citations to this article

Mutations in sodium-channel gene SCN9A cause a spectrum of human genetic pain disorders
Joost P.H. Drenth, Stephen G. Waxman
Joost P.H. Drenth, Stephen G. Waxman
Published December 3, 2007
Citation Information: J Clin Invest. 2007;117(12):3603-3609. https://doi.org/10.1172/JCI33297.
View: Text | PDF
Science in Medicine Article has an altmetric score of 67

Mutations in sodium-channel gene SCN9A cause a spectrum of human genetic pain disorders

Abstract

The voltage-gated sodium-channel type IX α subunit, known as Nav1.7 and encoded by the gene SCN9A, is located in peripheral neurons and plays an important role in action potential production in these cells. Recent genetic studies have identified Nav1.7 dysfunction in three different human pain disorders. Gain-of-function missense mutations in Nav1.7 have been shown to cause primary erythermalgia and paroxysmal extreme pain disorder, while nonsense mutations in Nav1.7 result in loss of Nav1.7 function and a condition known as channelopathy-associated insensitivity to pain, a rare disorder in which affected individuals are unable to feel physical pain. This review highlights these recent developments and discusses the critical role of Nav1.7 in pain sensation in humans.

Authors

Joost P.H. Drenth , Stephen G. Waxman

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 Total
Citations: 5 8 12 5 9 11 12 8 9 8 3 6 8 7 8 13 9 4 145
Citation information

Citations to this article in year 2020 (11)

Title and authors Publication Year
Pentameric Ligand-Gated Ion Channels as Pharmacological Targets Against Chronic Pain
CO Lara, CF Burgos, G Moraga-Cid, MA Carrasco, GE Yévenes 		Frontiers in pharmacology 2020
Computational pipeline to probe NaV1.7 gain-of-function variants in neuropathic painful syndromes
AA Toffano, G Chiarot, S Zamuner, M Marchi, E Salvi, SG Waxman, CG Faber, G Lauria, A Giacometti, M Simeoni 		Scientific Reports 2020
Unusual Pain Disorders – What Can Be Learned from Them?
J Sachau, D Kersebaum, R Baron, AH Dickenson 		Journal of pain research 2020
An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipids
S Ferdinandusse, K McWalter, H te Brinke, L IJlst, PM Mooijer, JP Ruiter, AE van Lint, M Pras-Raves, E Wever, F Millan, MJ Sacoto, A Begtrup, M Tarnopolsky, L Brady, RL Ladda, SL Sell, CB Nowak, J Douglas, C Tian, E Ulm, S Perlman, AV Drack, K Chong, N Martin, J Brault, E Brokamp, C Toro, WA Gahl, EF Macnamara, L Wolfe, ME Alejandro, MS Azamian, CA Bacino, A Balasubramanyam, LC Burrage, HT Chao, GD Clark, WJ Craigen, H Dai, SU Dhar, LT Emrick, AM Goldman, NA Hanchard, F Jamal, L Karaviti, SR Lalani, BH Lee, RA Lewis, R Marom, PM Moretti, DR Murdock, SK Nicholas, JP Orengo, JE Posey, L Potocki, JA Rosenfeld, SL Samson, DA Scott, AA Tran, TP Vogel, MF Wangler, S Yamamoto, CM Eng, P Liu, PA Ward, E Behrens, M Deardorff, M Falk, K Hassey, K Sullivan, A Vanderver, DB Goldstein, H Cope, A McConkie-Rosell, K Schoch, V Shashi, EC Smith, RC Spillmann, JA Sullivan, QK Tan, NM Walley, PB Agrawal, AH Beggs, GT Berry, LC Briere, LA Cobban, M Coggins, CM Cooper, EL Fieg, F High, IA Holm, S Korrick, JB Krier, SA Lincoln, J Loscalzo, RL Maas, CA MacRae, JC Pallais, DA Rao, LH Rodan, EK Silverman, JM Stoler, DA Sweetser, M Walker, CA Walsh, C Esteves, EG Kelley, IS Kohane, K LeBlanc, AT McCray, A Nagy, S Dasari, BC Lanpher, IR Lanza, E Morava, D Oglesbee, G Bademci, D Barbouth, S Bivona, O Carrasquillo, TC Chang, I Forghani, A Grajewski, R Isasi, B Lam, R Levitt, XZ Liu, J McCauley, R Sacco, M Saporta, J Schaechter, M Tekin, F Telischi, W Thorson, S Zuchner, HA Colley, JG Dayal, DJ Eckstein, LC Findley, DM Krasnewich, LA Mamounas, TA Manolio, JJ Mulvihill, GL LaMoure, MP Goldrich, TK Urv, AL Doss, MT Acosta, C Bonnenmann, P DSouza, DD Draper, C Ferreira, RA Godfrey, CA Groden, EF Macnamara, VV Maduro, TC Markello, A Nath, D Novacic, BN Pusey, C Toro, CE Wahl, E Baker, EA Burke, DR Adams, WA Gahl, MC Malicdan, CJ Tifft, LA Wolfe, J Yang, B Power, B Gochuico, L Huryn, L Latham, J Davis, D Mosbrook-Davis, F Rossignol, B Solomon, J MacDowall, A Thurm, W Zein, M Yousef, M Adam, L Amendola, M Bamshad, A Beck, J Bennett, B Berg-Rood, E Blue, B Boyd, P Byers, S Chanprasert, M Cunningham, K Dipple, D Doherty, D Earl, I Glass, K Golden-Grant, S Hahn, A Hing, FM Hisama, M Horike-Pyne, GP Jarvik, J Jarvik, S Jayadev, C Lam, K Maravilla, H Mefford, JL Merritt, G Mirzaa, D Nickerson, W Raskind, N Rosenwasser, CR Scott, A Sun, V Sybert, S Wallace, M Wener, T Wenger, EA Ashley, G Bejerano, JA Bernstein, D Bonner, TR Coakley, L Fernandez, PG Fisher, L Fresard, J Hom, Y Huang, JN Kohler, E Kravets, MM Majcherska, BA Martin, S Marwaha, CE McCormack, AN Raja, CM Reuter, M Ruzhnikov, JB Sampson, KS Smith, S Sutton, HK Tabor, BM Tucker, MT Wheeler, DB Zastrow, C Zhao, WE Byrd, AB Crouse, M Might, M Nakano-Okuno, J Whitlock, G Brown, MJ Butte, EC DellAngelica, N Dorrani, ED Douine, BL Fogel, I Gutierrez, A Huang, D Krakow, H Lee, SK Loo, BC Mak, MG Martin, JA Martínez-Agosto, E McGee, SF Nelson, S Nieves-Rodriguez, CG Palmer, JC Papp, NH Parker, G Renteria, RH Signer, JS Sinsheimer, J Wan, L Wang, KW Perry, JD Woods, J Alvey, A Andrews, J Bale, J Bohnsack, L Botto, J Carey, L Pace, N Longo, G Marth, P Moretti, A Quinlan, M Velinder, D Viskochil, P Bayrak-Toydemir, R Mao, M Westerfield, A Bican, E Brokamp, L Duncan, R Hamid, J Kennedy, M Kozuira, JH Newman, JA Phillips, L Rives, AK Robertson, E Solem, JD Cogan, FS Cole, N Hayes, D Kiley, K Sisco, J Wambach, D Wegner, D Baldridge, S Pak, T Schedl, J Shin, L Solnica-Krezel, Q Waisfisz, PJ Zwijnenburg, A Ziegler, M Barth, R Smith, S Ellingwood, D Gaebler-Spira, S Bakhtiari, MC Kruer, AH van Kampen, RJ Wanders, HR Waterham, D Cassiman, FM Vaz 		Genetics in Medicine 2020
Status of peripheral sodium channel blockers for non-addictive pain treatment
M Alsaloum, GP Higerd, PR Effraim, SG Waxman 		Nature Reviews Neurology 2020
Resilience to Stress and Resilience to Pain: Lessons from Molecular Neurobiology and Genetics
EJ Nestler, SG Waxman 		Trends in Molecular Medicine 2020
Application of Pharmacokinetic-Pharmacodynamic Modeling to Inform Translation of In Vitro NaV1.7 Inhibition to In Vivo Pharmacological Response in Non-human Primate
JE Ballard, P Pall, J Vardigan, F Zhao, MA Holahan, R Kraus, Y Li, D Henze, A Houghton, CS Burgey, C Gibson 		Pharmaceutical Research 2020
Discovery and validation of biomarkers to aid the development of safe and effective pain therapeutics: challenges and opportunities
KD Davis, N Aghaeepour, AH Ahn, MS Angst, D Borsook, A Brenton, ME Burczynski, C Crean, R Edwards, B Gaudilliere, GW Hergenroeder, MJ Iadarola, S Iyengar, Y Jiang, JT Kong, S Mackey, CY Saab, CN Sang, J Scholz, M Segerdahl, I Tracey, C Veasley, J Wang, TD Wager, AD Wasan, MA Pelleymounter 		Nature Reviews Neurology 2020
Understanding the genetic basis of congenital insensitivity to pain
I Drissi, WA Woods, CG Woods 		British Medical Bulletin 2020
Novel mutation of SCN9A gene causing generalized epilepsy with febrile seizures plus in a Chinese family
T Zhang, M Chen, A Zhu, X Zhang, T Fang 		Neurological Sciences 2020
Population Study of Hand and Wrist Manifestations of Congenital Insensitivity to Pain
Spiteri M, Mifsud M, Azzopardi T, Giele H 		Hand (New York, N.Y.) 2020

Advertisement